Skin Disorders News

Data showed that not all patients with chronic inflammatory skin diseases undergo pretreatment testing before initiating systemic immunomodulatory therapies, despite current guidelines, according to a study.

MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.

Delgocitinib cream demonstrated superiority to alitretinoin capsules in the treatment of severe chronic hand eczema, LEO Pharma announced in a press release.

Children and adolescents with difficult-to-control atopic dermatitis can benefit from a multidisciplinary approach that combines the perspectives of dermatologists, allergists and family members, according to a study.

Dermavant Sciences has submitted a supplemental new drug application to the FDA for its Vtama cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older, according to a company press release.

Vegetarian diets during pregnancy were associated with reduced risks for atopic dermatitis among children, according to a study published in Pediatric Allergy and Immunology.

The FDA and the European Medicines Agency have accepted applications for nemolizumab for the treatment of prurigo nodularis and severe atopic dermatitis in adolescents and adults, Galderma announced in a press release.

MIAMI BEACH, Fla. — Patients with atopic dermatitis resistant to systemic therapy, including dupilumab, may benefit from tralokinumab treatment, according to a poster presentation here.

MIAMI BEACH, Fla. — Clinicians should consider implementing an action plan for eczema treatment to maximize patient education, according to a presentation at the Masters of Pediatric Dermatology meeting.

MIAMI BEACH, Fla. — Pediatric dermatologists should be open with patients and families when discussing boxed warnings while emphasizing that the benefits outweigh the risks, according to a speaker here.